Cargando…
A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes
BACKGROUND: An increasing number of studies show that genetic markers can aid in refining prognostic information and predicting the benefit from systemic therapy. Our goal was to develop a high throughput, cost-effective and simple methodology for the detection of clinically relevant hot spot mutati...
Autores principales: | Fumagalli, Debora, Gavin, Patrick G, Taniyama, Yusuke, Kim, Seung-Il, Choi, Hyun-Joo, Paik, Soonmyung, Pogue-Geile, Katherine L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845115/ https://www.ncbi.nlm.nih.gov/pubmed/20233444 http://dx.doi.org/10.1186/1471-2407-10-101 |
Ejemplares similares
-
Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology)
por: Kim, S Rim, et al.
Publicado: (2018) -
Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831
por: Pogue-Geile, Katherine L, et al.
Publicado: (2020) -
Integrated Ratio of Metastatic to Examined Lymph Nodes and Number of Metastatic Lymph Nodes into the AJCC Staging System for Colon Cancer
por: Gao, Peng, et al.
Publicado: (2012) -
Importance of Metastatic Lymph Node Ratio in Non-Metastatic, Lymph Node-Invaded Colon Cancer: A Clinical Trial
por: Isik, Arda, et al.
Publicado: (2014) -
Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer
por: Baqar, Ali Riaz, et al.
Publicado: (2020)